The American Society of Clinical Oncology (ASCO) and the Community Oncology Alliance (COA) have jointly released new Oncology Medical Home (OMH) standards, which they say provide a comprehensive roadmap for oncology practices to deliver high-quality, evidence-based cancer care.
An Oncology Medical Home is a system of care delivery that features coordinated, efficient, accessible, evidence-based care and includes a process for measurement of outcomes as a means of facilitating continuous quality improvement. It is based on the patient-centered medical home model.
These standards, which were published in JCO Oncology Practice, are designed to establish core elements needed to deliver equitable, high-quality cancer care. In releasing the new standards, ASCO and COA seek to achieve a broad consensus among all stakeholders—including patients, clinicians, payers, purchasers, and employers—on what patients with cancer should expect and receive from their cancer care teams.
“Every single patient has the right to high-quality, evidence-based, and cost-effective cancer care. However, our challenge as clinicians and as a broader oncology community has been to define what that high-quality cancer care looks like,” said ASCO President Everett E. Vokes, M.D., in a statement. “These new, comprehensive standards will remove ambiguity and serve as a strong foundation for all stakeholders to work together to ensure that every single person receives the care they deserve, throughout the entire patient journey.”
According to ASCO and COA, implementation of the OMH standards will address issues such as appropriate use and safe and efficient delivery of oncology drugs, patient-centered care coordination, effective communication, informed decision making, and planning. ASCO and COA say the standards provide an opportunity for the entire oncology community to work toward a value-based model of care that will benefit all patients with cancer.
“These new OMH standards provide oncology practices with a single set of cancer care delivery expectations that benefit patients, practices, and other stakeholders,” said COA President Kashyap Patel, M.D., in a statement. “As practices transition into value-based care delivery, those that adopt this framework will be able to focus on a standardized process that measurably demonstrates high-quality, patient-centered, and efficient care.”
The ASCO/COA standards will form the foundation of a two-year, ASCO-led OMH certification pilot. More details about the pilot will be announced in the coming months.
The new OMH standards feature seven domains of cancer care. Specifically, the standards include:
1. Patient engagement in and empowerment to share in decision-making about their cancer care. This includes individualized treatment plans, survivorship plans, and access to financial navigation.
2. Patient access to cancer care at the right time, in the right setting. Providers should use a symptom triage system and offer expanded access to timely office care to minimize emergency room visits.
3. Evidence and value-based treatment. Providers should adhere and document their adherence to comprehensive clinical pathways that reflect the latest clinical research, and should recommend and refer patients to clinical trials (as appropriate).
4. Patient access to equitable, comprehensive, and coordinated, team-based care. Oncology care teams should closely coordinate each patient’s care, and include patient navigation, psychosocial care, and support services as part of the care team. Practices must have policies in place to address health equity, including awareness of conscious/unconscious bias.
5. Continuous practice quality improvement using data, including patient surveys and patient-reported outcomes, to evaluate and improve processes and outcomes.
6. Patient access to advance care planning discussions, palliative, and end-of-life care. Practices should also hold a ‘goals of care’ discussion with all patients.
7. Practice adherence to the highest-level chemotherapy safety standards.
